SCHEMBL2927013

SCHEMBL2927013

Nc1cc(Cl)c(S)c(Cl)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 7/20 0.58
ALDH1A1 P00352 7/20 0.58
THRB P10828 2/20 0.52
TSHR P16473 7/20 0.46
TP53 P04637 2/20 0.45
GAA P10253 2/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
ALOX15 P16050 2/20 0.34
HSD17B10 Q99714 2/20 0.34
HPGD P15428 1/20 0.34
CASP1 P29466 1/20 0.34
RECQL P46063 1/20 0.34
PDE7A Q13946 1/20 0.33
POLB P06746 1/20 0.32
HTT P42858 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
ITGB2 P05107 1/20 0.32
ICAM1 P05362 1/20 0.32
ITGAL P20701 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11014169 0.82 CYP3A4 (0.48) CYP3A4ALDH1A1THRBTSHRTP53
SCHEMBL292270 0.73 CYP3A4 (1.00) CYP3A4ALDH1A1THRBTSHRTP53
SCHEMBL330561 0.73 CYP3A4 (0.65) CYP3A4ALDH1A1THRBTSHRTP53
SCHEMBL1353155 0.73 THRB (0.67) CYP3A4ALDH1A1THRBTSHRTP53
SCHEMBL9294483 0.73 TTR (0.47) CYP3A4ALDH1A1TSHRGAAMAPK1
SCHEMBL1392834 0.73 ALDH1A1 (0.53) CYP3A4ALDH1A1THRBTSHRTP53
SCHEMBL7185761 0.73 TRPV4 (0.39) CYP3A4ALDH1A1GAAMAPK1
SCHEMBL8840260 0.71 ALDH1A1 (0.61) CYP3A4ALDH1A1THRBTSHRTP53
Hydrochloric Acid SCHEMBL8840292 0.71 CYP3A4 (0.61) CYP3A4ALDH1A1THRBTSHRTP53
SCHEMBL28421611 0.71 CYP3A4 (0.61) CYP3A4ALDH1A1THRBTSHRTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3840755-B1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS TERNS INC (US) 2026-02-18 EP disclosed
US-20250236615-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS Terns, Inc. 2025-07-24 US disclosed
WO-2024141104-A1 NEW PYRIDAZINE COMPOUND, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF 南京知和医药科技有限公司 2024-07-04 WO disclosed
CN-117843621-A Novel pyridazine compound, and pharmaceutical composition and application thereof 南京知和医药科技有限公司 2024-04-09 CN disclosed
US-20230257367-A1 NOVEL THYROID HORMONE BETA RECEPTOR AGONIST CHENGDU KANGHONG PHARMACEUTICAL CO., LTD. (CN) 2023-08-17 US disclosed
US-20230257367-A1 NOVEL THYROID HORMONE BETA RECEPTOR AGONIST CHENGDU KANGHONG PHARMACEUTICAL CO., LTD. (CN) 2023-08-17 US disclosed
EP-4159723-A1 NOVEL THYROID HORMONE ß RECEPTOR AGONIST Chengdu Kanghong Pharmaceutical Co., Ltd. (CN) 2023-04-05 EP disclosed
US-20210355110-A1 THYROID HORMONE RECEPTOR AGONISTS InventisBio Co., Ltd. (CN) 2021-11-18 US disclosed
CN-112805005-A Thyroxine receptor beta agonist compounds 拓臻股份有限公司 2021-05-14 CN disclosed
US-10800767-B2 Thyroid hormone receptor beta agonist compounds Terns, Inc. (US) 2020-10-13 US disclosed
US-7452882-B2 Thyroid hormone analogs HOFFMANN-LA ROCHE INC. (US) 2008-11-18 US disclosed
EP-1919878-A1 PYRIDAZINONE DERIVATIVES AS THYROID HORMONE RECEPTOR AGONISTS F. Hoffmann-Roche AG (CH) 2008-05-14 EP disclosed
US-20070032494-A1 Thyroid hormone analogs HOFFMANN-LA ROCHE INC. 2007-02-08 US disclosed
US-20070032494-A1 Thyroid hormone analogs HOFFMANN-LA ROCHE INC. 2007-02-08 US disclosed
US-20070032494-A1 Thyroid hormone analogs HOFFMANN-LA ROCHE INC. 2007-02-08 US disclosed
WO-2007009913-A1 PYRIDAZINONE DERIVATIVES AS THYROID HORMONE RECEPTOR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2007-01-25 WO disclosed
WO-2007009913-A1 PYRIDAZINONE DERIVATIVES AS THYROID HORMONE RECEPTOR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2007-01-25 WO disclosed
US-4898608-A Pyridylthio-acylanilide herbicides BAYER AKTIENGESELLSCHAFT (DE) 1990-02-06 US disclosed
EP-0243868-A2 Pyridylthio-acylanilides BAYER AG (DE) 1987-11-04 EP disclosed
EP-0143302-A2 Benzoylurea derivatives and intermediates NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1985-06-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032494-A1 Thyroid hormone analogs THRA, THRB, TPO CYP3A4 401/4885ALDH1A1 991/4885THRB 2/4885
US-20210355110-A1 THYROID HORMONE RECEPTOR AGONISTS TSHR, THRA, TRHR CYP3A4 787/4885ALDH1A1 1881/4885THRB 4/4885
US-20230257367-A1 NOVEL THYROID HORMONE BETA RECEPTOR AGONIST THRB, THRA, TSHR CYP3A4 749/4885ALDH1A1 1538/4885THRB 1/4885
US-20250236615-A1 THYROID HORMONE RECEPTOR BETA AGONIST COMPOUNDS THRB, THRA, TSHR CYP3A4 2854/4885ALDH1A1 3553/4885THRB 1/4885
US-10800767-B2 Thyroid hormone receptor beta agonist compounds THRB, THRA, TSHR CYP3A4 2854/4885ALDH1A1 3553/4885THRB 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.